Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hinge Health Inc Cl A (HNGE)

Hinge Health Inc Cl A (HNGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,794,256
  • Shares Outstanding, K 78,719
  • Annual Sales, $ 390,404 K
  • Annual Income, $ -11,933 K
  • EBIT $ 0 M
  • EBITDA $ 0 M
  • 60-Month Beta N/A
  • Price/Sales 7.10
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 53.01% (-2.08%)
  • Historical Volatility 43.84%
  • IV Percentile 1%
  • IV Rank 0.00%
  • IV High 112.26% on 06/23/25
  • IV Low 53.01% on 12/24/25
  • Expected Move (DTE 22) 4.38 (9.08%)
  • Put/Call Vol Ratio 0.33
  • Today's Volume 122
  • Volume Avg (30-Day) 545
  • Put/Call OI Ratio 0.62
  • Today's Open Interest 9,937
  • Open Int (30-Day) 12,862
  • Expected Range 43.82 to 52.58

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.04
  • Number of Estimates 2
  • High Estimate 0.16
  • Low Estimate -0.08
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
45.52 +5.89%
on 12/04/25
51.35 -6.13%
on 11/26/25
+1.19 (+2.53%)
since 11/24/25
3-Month
39.19 +22.99%
on 11/18/25
54.40 -11.40%
on 10/08/25
-6.03 (-11.12%)
since 09/24/25

Most Recent Stories

More News
Hinge Health Reduces MRIs and X-Rays for Back Pain by 60%

Hinge Health, Inc. (NYSE: HNGE) today announced a new study showing that participants in its chronic back pain program had substantially fewer imaging visits, such as X-rays and MRIs, compared...

HNGE : 48.20 (-1.15%)
Hinge Health announces $250 million share repurchase program

Hinge Health, Inc. (NYSE: HNGE) today announced that its board of directors has authorized a $250 million share repurchase program. “During the first three quarters of 2025, we generated...

HNGE : 48.20 (-1.15%)
Hinge Health reports third quarter 2025 financial results

Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the third quarter ended September 30, 2025. “With healthcare costs rising dramatically, our mission to automate care delivery...

HNGE : 48.20 (-1.15%)
Hinge Health unveils new AI-powered care tools

Hinge Health, Inc. (NYSE:HNGE) today announced two AI-powered care tools: Movement Analysis uses computer vision to set a new standard for tracking musculoskeletal (MSK) outcomes, and Robin is an AI Care...

HNGE : 48.20 (-1.15%)
Hinge Health Reports Second Quarter 2025 Financial Results

Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the second quarter ended June 30, 2025. "In Q2 we delivered year-over-year revenue growth of 55% and a strong free cash flow...

HNGE : 48.20 (-1.15%)
Should You Buy Omada Health Stock After the OMDA IPO?

The health tech company is currently trading below its IPO price of $23 per share.

CVS : 79.12 (+1.38%)
ETOR : 35.95 (-0.75%)
HNGE : 48.20 (-1.15%)
CI : 274.86 (+0.41%)
CRCL : 82.64 (-0.11%)
OMDA : 15.92 (+4.19%)
Should You Buy Hinge Health After the HNGE Stock IPO?

Hinge Health stock recently went public via an IPO. Is the health-tech company a good buy right now given its steady revenue and earnings growth profile?

HNGE : 48.20 (-1.15%)

Business Summary

Hinge Health Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain and post-surgical rehabilitation. Hinge Health Inc. is based in San Francisco, California.

See More

Key Turning Points

3rd Resistance Point 49.98
2nd Resistance Point 49.58
1st Resistance Point 48.89
Last Price 48.20
1st Support Level 47.80
2nd Support Level 47.40
3rd Support Level 46.71

See More

52-Week High 62.18
Fibonacci 61.8% 51.19
Last Price 48.20
Fibonacci 50% 47.80
Fibonacci 38.2% 44.41
52-Week Low 33.42

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar